|
|
|
Market Cap (in crs)
3,207.63
Face Value
10
Turnover (in lacs)
968.22
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
137.99 Cr | 114.21 Cr | 103.02 Cr | 180.21 Cr | 0.8 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
417.51 Cr | 217.34 Cr | 39.02 Cr | 14.63 Cr |
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
21.18 Cr | 17.97 Cr | 16.43 Cr | 23.83 Cr | 0.11 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
58.34 Cr | 32.71 Cr | 8.43 Cr | 0.99 Cr |
Senores Pharmaceuticals Ltd reported a 35.0% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1FY26). On a year-on-year (YoY) basis, it witnessed a growth of 17350.6%.
Its expenses for the quarter were down by 40.3% QoQ and up 16791.2% YoY.
The net profit decreased 35.2% QoQ and increased 19154.5% YoY.
The earnings per share (EPS) of Senores Pharmaceuticals Ltd stood at 4.6 during Q1FY26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 81951 Rs | 149044 Rs |
Week Rs | 114819 Rs | 233023 Rs |
Month Rs | 135312 Rs | 340265 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
103.72 | 2,663.34 | 85.46 | 166.75 | 101.80 | 0.08% | -6.74% | 16.57% | -32.75% | 41.69% | 2.31% | 18.72 | 100.83 | 3.12 | |
269.30 | 3,320.49 | 245 | 464.75 | 256.40 | 5.30% | -15.11% | -21.56% | -18.18% | -19.34% | 0.30% | 52.66 | 40.11 | 2.63 | |
95.23 | 2,795.26 | 57.5 | 107.54 | 93.14 | 3.69% | -4.93% | 56.71% | 9.07% | 32.15% | 0.84% | 26.55 | 40.11 | 1.66 | |
506.10 | 3,563.24 | 483 | 937.95 | 504.30 | -4.22% | -16.68% | -21.92% | -11.47% | 58.28% | 0.00% | 26.20 | 40.11 | 1.45 | |
1,205.60 | 3,655.13 | 535 | 1397.3 | 1,207.50 | 0.11% | -0.54% | 48.79% | 77.53% | 353.23% | 0.08% | 282.34 | 40.11 | 8.42 | |
630.60 | 2,798.24 | 442.8 | 882.8 | 634.75 | 3.71% | 4.33% | 40.04% | -14.54% | 55.05% | 0.00% | 105.00 | 40.11 | 2.09 |
Senores Pharmaceuticals share price is ₹696.5 in NSE and ₹695.95 in BSE as on 2/9/2025.
Senores Pharmaceuticals share price in the past 1-year return was 0. The Senores Pharmaceuticals share hit a 1-year low of Rs. 435.25 and a 1-year high of Rs. 737.85.
The market cap of Senores Pharmaceuticals is Rs. 3207.63 Cr. as of 2/9/2025.
The PE ratios of Senores Pharmaceuticals is 0 as of 2/9/2025.
The PB ratios of Senores Pharmaceuticals is 4.52 as of 2/9/2025
The Mutual Fund Shareholding in Senores Pharmaceuticals was 3% at the end of 2/9/2025.
You can easily buy Senores Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Senores Pharmaceuticals share price is ₹737.85 and ₹435.25 as of 2/9/2025.
The earnings per share (EPS) of Senores Pharmaceuticals stood at 4.6 during Q1FY26.
Please be aware that Senores Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.